Concept Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1979.
1979 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Concept Pharmaceuticals Limited

Concept Pharmaceuticals Limited, a active public limited company, was established on 20 March 1979 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH1979PLC021126. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹16.00 Cr and a paid-up capital of ₹12.00 Cr.

Formerly known as Concept Pharmaceuticals Private Limited. It upholds a active non-compliant status. Employing 519 professional, Its leadership includes Rekha Adhyatma Gupta (Additional Director), Yugin Adhyatma Gupta (Director), Ved Parkash Kumar (Director). Past directors included Adhyatma Bandhu Gupta, Rekha Adhyatma Gupta, Yugin Adhyatma Gupta. It holds ₹280.33 Cr open charges and ₹77.95 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 801-B, Hubtown Solaris, N.S. Phadke Marg, Off. Teli Galli, Near Andheri Flyover, A, Ndheri (E), Mumbai, Maharashtra, 400069.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH1979PLC021126

  • Registration Number

    021126

  • Incorporation Date

    20 March 1979

  • Authorized Capital

    ₹16.00 Cr

  • Paid-Up Capital

    ₹12.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 16.00 Cr
  • Paid Up Capital ₹ 12.00 Cr
  • Company Age 46 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 280.33 Cr
  • Satisfied Charges ₹ 77.95 Cr
  • Revenue Growth **** -28.92%
  • Profit Growth **** -42.09%
  • Ebitda **** -5.98%
  • Net Worth 0.71%
  • Total Assets **** 4.97%
Company report

Concept Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Concept Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Concept Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Rekha Adhyatma Gupta Additional Director 15 Jan 2025 Current
Yugin Adhyatma Gupta Director 01 Nov 2012 Current
Ved Parkash Kumar Director 29 Sep 1995 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 08 Jan 2025 Past
Pramod Abcsdd Whole-Time Director 01 Nov 2012 Past
Pramod Abcsdd Additional Director 30 Mar 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Concept Pharmaceuticals.

Concept Pharmaceuticals Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 28.92% decrease. The company also saw a substantial fall in profitability, with a 42.09% decrease in profit. The company's net worth moved up by a moderate rise of 0.71%.

Concept Pharmaceuticals revenue growth over time
Concept Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -28.92%
*******
*******
*******
*******
Revenue from Operations
*******
 -28.93%
*******
*******
*******
*******
Total Assets
*******
 4.97%
*******
*******
*******
*******
Profit or Loss
*******
 -42.09%
*******
*******
*******
*******
Net Worth
*******
 0.71%
*******
*******
*******
*******
EBITDA
*******
 -5.98%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Concept Pharmaceuticals?

In 2024, Concept Pharmaceuticals had a promoter holding of 0.03% and a public holding of 99.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,803,300,000.00

Satisfied Charges

₹779,492,340.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 247.00 Cr
  • Others : 7.89 Cr
  • Dena Bank : 7.56 Cr
  • Oman International Bank : 5.88 Cr
  • Bank Of Baroda : 4.30 Cr
  • Others : 7.70 Cr
Latest Charge Details
Date Lender Amount Status
27 Feb 2025 Canara Bank ₹49.00 Cr Open
14 Oct 2024 Others ₹2.50 Cr Open
27 Sep 2022 The Hongkong And Shanghai Banking Corporation Limited ₹3.00 Cr Open
18 Nov 2021 Others ₹3.73 Cr Open
12 Mar 2021 Canara Bank ₹43.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Concept Pharmaceuticals?

Concept Pharmaceuticals has a workforce of 519 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Concept Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concept Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Concept Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Canara Bank of Rs. 155.00 Cr registered on 22 Apr 1983 with Charge ID 90216863 was modified on 29 Aug 2025. was completed.

  • Charges

    The activity A charge with Canara Bank amounted to Rs. 49.00 Cr with Charge ID 101069693 was registered on 27 Feb 2025. was completed.

  • Director Appointment

    Progress on Rekha Adhyatma Gupta was appointed as a Additional Director was appointed as a Additional Director on 15 Jan 2025 & has been associated with this company since 1 year 28 days . was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 2.50 Cr with Charge ID 101003440 was registered on 14 Oct 2024. was completed.

  • Annual General Meeting

    Concept Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Concept Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Concept Pharmaceuticals Limited?

The CIN of Concept Pharmaceuticals Limited is U24239MH1979PLC021126.

Where is Concept Pharmaceuticals Limited headquartered?

Concept Pharmaceuticals Limited is headquartered at 801-B, Hubtown Solaris, N.S. Phadke Marg, Off. Teli Galli, Near Andheri Flyover, A, Ndheri (E), Mumbai, Maharashtra, 400069.

When was Concept Pharmaceuticals Limited incorporated?

Concept Pharmaceuticals Limited was incorporated on 20 March 1979.

Who are the current directors of Concept Pharmaceuticals Limited?

The current directors of Concept Pharmaceuticals Limited are

What is the primary industry of Concept Pharmaceuticals Limited?

The primary industry of Concept Pharmaceuticals Limited is Manufacturing.

Is Concept Pharmaceuticals Limited a listed company?

Concept Pharmaceuticals Limited is unlisted.

What is the capital structure of Concept Pharmaceuticals Limited?

The authorized capital of Concept Pharmaceuticals Limited is ₹16.00 Cr, and the paid-up capital is ₹12.00 Cr.

What is the compliance status of Concept Pharmaceuticals Limited?

The compliance status of Concept Pharmaceuticals Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available